Yum Brands to review strategic options for Pizza Hut, opening the door to a sale

Yum Brands to review strategic options for Pizza Hut, opening the door to a sale


A Pizza Hut store is seen on November 01, 2023 in Austin, Texas. Pizza Hut’s third-quarter revenue fell short of analysts’ expectations for same-store sales. 

Brandon Bell | Getty Images

Yum Brands on Tuesday announced that it will explore strategic options for Pizza Hut.

“The Pizza Hut team has been working hard to address business and category challenges; however, Pizza Hut’s performance indicates the need to take additional action to help the brand realize its full value, which may be better executed outside of Yum! Brands,” Yum CEO Chris Turner said in a statement.

The company has not set a deadline or definitive timetable for the review process. While Yum did not specify what the review’s “range of strategic options” include, potential outcomes could be an outright divestiture, a joint venture or the sale of a stake in the chain.

Pizza Hut has been a part of a triumvirate with KFC and Taco Bell for decades, dating back to when PepsiCo still owned the fast-food chains. The beverage giant spun off the restaurants in 1997, christening the new company Tricon Global, later renamed to Yum.

Tuesday’s announcement caps years of struggle for Pizza Hut.

Before the pandemic, it tried to shrug off its reputation as a dine-in venue and reposition itself as an option for pizza delivery and carryout in the U.S. When Covid-19 lockdowns shuttered restaurants, the chain saw its sales skyrocket, like the rest of its pizza industry. But once restrictions loosened, so-called “pizza fatigue” settled in, leading to another sales slump.

And now, with consumers dining out less often, Pizza Hut is facing increased competition for a smaller set of diners. The chain’s share of the U.S. pizza market has shrunk from 22.6% in 2019 to 18.7% in 2024, ceding customers to rival Domino’s Pizza, according to Barclays.

In the wake of the pullback of consumer spending, other restaurant companies have recently shed challenged parts of their businesses in an effort to improve their balance sheets.

Starbucks on Monday announced that it is selling a majority stake in its embattled China business and will form a joint venture with Boyu Capital. Last month, Jack in the Box divested Del Taco for $115 million, well short of the $575 million it paid for the chain less than four years ago. And Krispy Kreme sold its remaining stake in Insomnia Cookies this summer to focus on growing its U.S. business profitably.



Source

Inside the booming business of wellness third spaces and membership clubs
Business

Inside the booming business of wellness third spaces and membership clubs

A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t have to involve alcohol. Newly sober and surrounded by friends who also chose not to drink, Guo said she wanted alternatives to the typical social scene. After some research, she landed on Bathhouse and Othership: […]

Read More
FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More